Nu Skin Enterprises (NUS)
(Delayed Data from NYSE)
$8.35 USD
0.00 (0.00%)
Updated Sep 5, 2024 04:00 PM ET
After-Market: $8.37 +0.02 (0.24%) 4:22 PM ET
5-Strong Sell of 5 5
A Value B Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.35 USD
0.00 (0.00%)
Updated Sep 5, 2024 04:00 PM ET
After-Market: $8.37 +0.02 (0.24%) 4:22 PM ET
5-Strong Sell of 5 5
A Value B Growth A Momentum A VGM
Zacks News
Inter Parfums (IPAR) Surges More Than 60% in a Year: Here's Why
by Zacks Equity Research
Inter Parfums (IPAR) has been focused on undertaking product launches to strengthen assortments. The company is expanding its business through strategic partnerships.
7 Low Price-to-Sales Stocks to Replenish Your Portfolio
by Rajani Lohia
Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like HIBB, BSET, NUS, MET, MT, KBH, and SMP are promising picks.
Nu Skin (NUS) Q2 Earnings Beat Estimates, Sales Grow Y/Y
by Zacks Equity Research
Nu Skin's (NUS) second-quarter 2021 earnings and revenues increase year over year on growth in sales leaders. Also, management raises 2021 earnings view.
Nu Skin Enterprises (NUS) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Nu Skin (NUS) delivered earnings and revenue surprises of 8.49% and 0.21%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Nu Skin (NUS) Queued for Q2 Earnings: Key Things to Note
by Zacks Equity Research
Nu Skin's (NUS) second-quarter 2021 performance is likely to reflect gains from the company's efforts to strengthen sales leader and expand customer. Also, online strength has been a driver.
Nu Skin Enterprises (NUS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Nu Skin (NUS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Estee Lauder Companies (EL) Up 61% in a Year: Here's How
by Zacks Equity Research
The Estee Lauder Companies (EL) has a strong online business. The company's Skin Care portfolio is performing well.
Coty's (COTY) Innovation Solid, Launches Touch-Less Fragrance Tester
by Zacks Equity Research
Coty (COTY) will introduce a digitally-enabled touch-less fragrance tester at beauty retailers in the next 12 months. Management expects to improve in-store sales via the launch.
Nu Skin (NUS) Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Nu Skin Enterprises (NUS) has been struggling lately, but the selling pressure may be coming to an end soon
Helen of Troy's (HELE) Q1 Earnings Top Estimates, Sales Up Y/Y
by Zacks Equity Research
Helen of Troy's (HELE) first-quarter fiscal 2022 results reflect growth in earnings and net sales on strength in all segments.
Buy These 5 Low Leverage Stocks to Keep Debt Risks Away
by Aparajita Dutta
The crux of safe investment lies in choosing a company that is not overburdened with debt as a debt-free stock is almost impossible to find. You may buy NUS, SON, NX, WRI and TD.
Inter Parfums (IPAR)-Salvatore Ferragamo Deal to Fuel Growth
by Zacks Equity Research
Inter Parfums (IPAR) inks a deal with Salvatore Ferragamo to fuel growth across the fragrance business.
New Strong Buy Stocks for July 2nd
by Zacks Equity Research
PIPR, TA, NUS, BKR, and LYB have been added to the Zacks Rank #1 (Strong Buy) List on July 2, 2021.
Coty's (COTY) Kylie Cosmetics Relaunch to Fortify Business
by Zacks Equity Research
Coty (COTY) relaunches Kylie Cosmetics, now formulated using clean and vegan ingredients with a revamped packaging. The launch will be available on direct-to-consumer site and at select retailers.
7 Low Price-to-Sales Stocks for Value-Focused Investors
by Rajani Lohia
Price-to-sales is a convenient tool to gauge the value of stocks that are incurring losses or are in an early development cycle. Stocks like NUS, FL, SIG, MET, MT, VSH and SMP are promising picks.
Nu Skin (NUS) Looks Promising: Stock Up More Than 45% in a Year
by Zacks Equity Research
Nu Skin (NUS) is focused on empowering sales leaders and customers through product launches and engaging technology platforms, among other initiatives.
Solid Skin Care & Online Sales Aid The Estee Lauder Companies (EL)
by Zacks Equity Research
The Estee Lauder Companies' (EL) Skin Care portfolio has been performing well for a while now. Also, the company's online operations look impressive.
4 Cosmetic Stocks to Watch as Consumers Get Ready to Head Out
by Vrishali Bagree
Focus on strengthening brands through innovation and product launches, along with increased use of cosmetics with people gradually stepping out, bodes well for The Estee Lauder (EL), Coty (COTY), Nu Skin (NUS) and Inter Parfums (IPAR).
Inter Parfums (IPAR) Looks Solid, Gains More Than 35% in 6 Months
by Zacks Equity Research
Inter Parfums (IPAR) has been gaining on constant product launches and strategic partnerships. The company's 2021 guidance looks encouraging.
Helen of Troy (HELE) Spins Off Market Personal Care Business
by Zacks Equity Research
Helen of Troy (HELE) divests mass market Personal Care business (excluding the Latin America and Caribbean regions) to HRB Brands LLC as part of its strategy to focus on Leadership Brands.
Zacks Industry Outlook Highlights: Estee Lauder, Coty, Nu Skin and Inter Parfums
by Zacks Equity Research
Zacks Industry Outlook Highlights: Estee Lauder, Coty, Nu Skin and Inter Parfums
4 Cosmetics Stocks Stealing Attention Despite Industry Woes
by Vrishali Bagree
The Zacks Cosmetics industry is battling COVID-19 hurdles like disrupted travel retail and low store traffic. However, high demand for personal care products and focus on innovation bodes well for Estee Lauder (EL), Coty (COTY), Nu Skin (NUS) and Inter Parfums (IPAR).
Nu Skin (NUS) Up 3.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Nu Skin (NUS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Coty (COTY) Poised on Strength in Core Priorities & Partnerships
by Zacks Equity Research
Coty (COTY) makes several strategic partnerships to enhance its brand portfolio. Also, it is on track with six priorities aimed at sustainable growth.
Nu Skin (NUS) Looks Buoyant on Product Launches & Online Sales
by Zacks Equity Research
Nu Skin (NUS) is benefiting from its focus on innovation and efforts to strengthen sales leader as well as expand customer base.